OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
TechCrunch
Read Full Article at TechCrunch →Ad Slot — In-Article (728x90)
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
This is a summary. For the full story, read the original article at TechCrunch.
Original source: TechCrunch